Your browser doesn't support javascript.
loading
Comparative nonclinical assessments of the biosimilar PF-06410293 and originator adalimumab.
Derzi, Mazin; Shoieb, Ahmed M; Ripp, Sharon L; Finch, Gregory L; Lorello, Leslie G; O'Neil, Shawn P; Radi, Zaher; Syed, Jameel; Thompson, Matthew S; Leach, Michael W.
Afiliação
  • Derzi M; Drug Safety Research and Development, Pfizer Inc., 300 Technology Square Drive, Cambridge, MA, USA. Electronic address: mazin.derzi@pfizer.com.
  • Shoieb AM; Drug Safety Research and Development, Pfizer Inc., Eastern Point Rd, Groton, CT, USA. Electronic address: ahmed.shoieb@pfizer.com.
  • Ripp SL; Pharmacokinetics, Dynamics & Metabolism, Pfizer Inc., Eastern Point Rd, Groton, CT, USA. Electronic address: sharon.l.ripp@pfizer.com.
  • Finch GL; Drug Safety Research and Development, Pfizer Inc., Eastern Point Rd, Groton, CT, USA. Electronic address: gtafinch@yahoo.com.
  • Lorello LG; Pharmacokinetics, Dynamics & Metabolism, Pfizer Inc., Eastern Point Rd, Groton, CT, USA. Electronic address: leslie.g.lorello@pfizer.com.
  • O'Neil SP; Drug Safety Research and Development, Pfizer Inc., 300 Technology Square Drive, Cambridge, MA, USA.
  • Radi Z; Drug Safety Research and Development, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA. Electronic address: zaher.radi@pfizer.com.
  • Syed J; Drug Safety Research and Development, Pfizer Inc., Eastern Point Rd, Groton, CT, USA. Electronic address: jameel.syed@pfizer.com.
  • Thompson MS; Analytical Research and Development, Pfizer Inc., 1 Burtt Rd, Andover, MA, USA. Electronic address: matthew.thompson@pfizer.com.
  • Leach MW; Drug Safety Research and Development, Pfizer Inc., 300 Technology Square Drive, Cambridge, MA, USA. Electronic address: michael.leach@pfizer.com.
Regul Toxicol Pharmacol ; 112: 104587, 2020 Apr.
Article em En | MEDLINE | ID: mdl-32006671
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Adalimumab Limite: Animals / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Adalimumab Limite: Animals / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2020 Tipo de documento: Article